BRIEF-Aratana Therapeutics says FDA approved its drug for appetite stimulation in dogs

* Intends to commercially launch Entyce in conjunction with North American Veterinary Conference in February 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.